Comparing glycemic control guidelines in diabetes care

Insulin

Volumn 1, Issue 1, 2006, Pages 13-21

  Singh, Nalini ^a,b   Haas, Linda B ^c  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

clinical guidelines; diabetes mellitus; glycemic control; glycosylated hemoglobin

Indexed keywords

INSULIN;

AMPUTATION; ARTICLE; BLINDNESS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; ECONOMIC ASPECT; EMOTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; INCIDENCE; INFORMATION DISSEMINATION; KIDNEY FAILURE; MEDICAL LITERATURE; MEDLINE; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRODUCTIVITY; PUBLICATION; STROKE;

EID: 33745509161     PISSN: 15570843     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1557-0843(06)80004-7     Document Type: Article

References (28)

1. Available at:. Centers for Disease Control and Prevention. National Diabetes Fact Sheet. Accessed (November 3, 2005). http://www.cdc.gov/diabetes/pubs/estimates05.htm#prev
2. International Diabetes Federation. Diabetes Atlas. Second Edition (2003), International Diabetes Federation;, Brussels, Belgium 17
3. Hogan P., Dall T., Nikolov P., and American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
5. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287 (2002) 2563-2569
6. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290 (2003) 2159-2167
7. San Diego, Calif. Nathan D. Effect of intensive diabetes management on cardiovascular events in type 1 DM. Late-breaking clinical trials. Presented at: ADA 65th Scientific Sessions (June 12, 2005)
8. [published correction appears in Lancet. 1999;354: 602]. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-group control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
9. [published correction appears in Lancet. 1998;352:1557]. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
10. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321 (2000) 405-412
11. Available at:. HA/DoD clinical practice guideline for the management of diabetes. Module 6: Glycemic Control. Accessed (July 22, 2005). http://www.ogp.med.va.gov/cpg/DM/DM3_cpg/content/ModG/annoG.htm
12. American Diabetes Association. American Diabetes Association: Clinical Practice Recommendations 2005. Standards of medical care in diabetes. Diabetes Care 28 Suppl 1 (2005) S10-S11
13. ACE Consensus Statement Writing Committee. American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control. Endocr Pract 8 Suppl 1 (2002) 5-11
14. Implementation Conference for ACE Outpatient Diabetes Mellitus Consensus Conference Recommendations: Position Statement (February 2, 2005). http://www.aace.com/pub/consensus.php
15. The American Association of Clinical Endocrinologists Medical. Guidelines for the Management of Diabetes Mellitus. The AACE system of intensive diabetes self management-2002 Update. Endocr Pract 8 Suppl 1 (2002) 41-65
16. Stratton I.M., Kohner E.M., Aldington S.J., et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44 (2001) 156-163
17. Khaw K.T., Wareham N., Luben R., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322 (2001) 15-18
18. Davidson J.A. Rationale for more aggressive guidelines for diabetes control. Endocr Pract 8 Suppl 1 (2002) 13-14
19. Skyler J.S. Evidence for glycated hemoglobin targets from the Diabetes Control and Complications Trial. Endocr Pract 8 Suppl 1 (2002) 27-30
20. Lebovitz H.E. Kumamoto and other studies: Is there more evidence? Epidemiologic and interventional studies. Endocr Pract 8 Suppl 1 (2002) 31-32
21. Holman R.R. Analysis of the United Kingdom Prospective Diabetes Study. Endocr Pract 8 Suppl 1 (2002) 33-34
22. Pogach L.M., Brietzke S.A., Cowan Jr. C.L., et al. Development of evidence-based clinical practice guidelines for diabetes. Diabetes Care 27 Suppl 2 (2002) B82-B89
23. Saaddine J.B., Engelgau M.M., Beckles G.L., et al. A diabetes report card for the United States: Quality of care in the 1990s. Ann Intern Med 136 (2002) 565-574
24. Grant R.W., Buse J.B., Meigs J.B., and University HealthSystem Consortium WHO Diabetes Benchmarking Project Team. Quality of diabetes care in U.S. academic medical centers: Low rates of medical regimen change. Diabetes Care 28 (2005) 337-442
25. American Diabetes Association. American Diabetes Association: Clinical Practice Recommendations 2005. Standards of medical care in diabetes. Diabetes Care 28 Suppl 1 (2005) 530-531
26. Kerr E.A., Gerzoff R.B., Krein S.L., et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: The TRIAD study. Ann Intern Med 141 (2004) 272-281
27. Nelson K.M., Chapko M.K., Reiber G., and Boyko E.L. The association between health insurance coverage and diabetes care; data from the 2000 Behavioral Risk Factor Surveillance System. Health Serv Res 40 (2005) 361-372
28. Asch S.M., McGlynn E.A., Hogan M.M., et al. Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med 141 (2004) 938-945